A 56-year-old woman experienced a perplexing decline in health, marked by neurological issues, heart palpitations, and thyroid dysfunction. Doctors initially struggled to pinpoint the cause, exploring deficiencies and autoimmune disorders. The woman's history of hip problems, including a recent revision surgery, eventually provided the critical clue.

Her revision surgery involved replacing a shattered ceramic hip liner with polyethylene and a ceramic ball with a cobalt-chromium alloy head. This seemingly routine procedure led to severe cobalt poisoning. Surgeons discovered a pool of grey, metallic fluid and necrotic tissue stained silver-gray with cobalt within the hip joint.

Doctors identified the source of her severe symptoms: toxic levels of cobalt leaching from the artificial hip component. Her blood cobalt levels were 592 ng/mL, far exceeding the normal <10 ng/mL. This case highlights the potential risks associated with cobalt-chromium alloys in hip implants, despite their use declining substantially.

Following a second revision surgery and chelation therapy, the woman's health showed some improvement, though nerve problems persisted. This incident serves as a stark reminder of the importance of material composition in long-term medical implants.